OU Researcher Utilizes Technology to Enhance Primary Care Interventions for Alcohol Disorders
According to recent statistics from the Centers for Disease Control and Prevention (CDC), approximately 1 in 7 adults in the United States will encounter a substance use disorder at some point in their lives. This staggering statistic reflects a growing public health crisis that demands attention from healthcare providers and researchers alike. Dr. Brandi Fink, […]

According to recent statistics from the Centers for Disease Control and Prevention (CDC), approximately 1 in 7 adults in the United States will encounter a substance use disorder at some point in their lives. This staggering statistic reflects a growing public health crisis that demands attention from healthcare providers and researchers alike. Dr. Brandi Fink, an associate professor at the University of Oklahoma College of Medicine, is at the forefront of addressing this complex issue, particularly focusing on alcohol use disorders through innovative, technology-driven solutions.
Dr. Fink has undertaken the challenge of developing a tool that can assist primary care clinics in identifying individuals who may be struggling with alcohol-related issues. Her creation, the Personal Alcohol Management System (PALMS), allows patients to engage with their health in a proactive manner. While waiting for their primary care appointments, individuals can complete an assessment on an iPad. The system provides immediate feedback regarding their alcohol consumption patterns, encouraging users to evaluate their drinking behaviors and consider steps to reduce their intake to safe levels. This dual approach not only benefits the patients but also equips healthcare providers with valuable insights that can inform subsequent discussions during their appointments.
In the initial phase of clinical trials, PALMS has received overwhelmingly positive feedback. Out of 235 patients who participated in this study, the average acceptance score amounted to an impressive 1.43 on a scale of 1 to 7—where one signifies utmost satisfaction. Usability also garnered high marks, with an 87 rating; scores above 80 are indicative of excellent design. Dr. Fink’s aspiration for PALMS is not merely to be a tool but a catalyst that brings alcohol consumption discussions to the forefront of healthcare interactions. By doing so, the hope is to dismantle the stigma and hesitations that often surround conversations about alcohol use.
One significant barrier that primary care physicians frequently encounter is the discomfort or uncertainty surrounding addressing alcohol-related issues during routine visits. Often, healthcare providers are pressed for time, and broaching the subject can feel like an unwelcome diversion from a patient’s immediate health concerns—such as managing diabetes or hypertension. Dr. Fink acknowledges this challenge, asserting that many providers feel ill-equipped to discuss potential alcohol problems with their patients, further compounding the difficulties in managing overall health. This is particularly concerning, as research suggests that a notable portion of individuals with a substance use disorder remain unaware of their condition and fail to seek assistance.
The parallels drawn between primary care visits and alcohol use disorder are striking. A staggering 20% of primary care patients may be engaging in hazardous drinking behavior, which presents complications in managing their overall health. This reality is particularly alarming as it can hinder the effective control of chronic diseases like diabetes and hypertension while also elevating the risk for various types of cancer. Dr. Fink’s initiative through PALMS aims to bridge this gap by facilitating constructive discussions about alcohol consumption, ultimately enabling healthcare providers to direct interventions where they are most needed.
Looking ahead, Dr. Fink is gearing up for the next phase of the clinical trial, which will focus on assessing the success of PALMS in effecting a reduction in harmful drinking habits among participants. A significant component of future iterations includes the integration of the assessment tool into electronic health records (EHR) systems. This pivot is designed to empower patients by allowing them to engage with the assessment in the comfort of their own homes, often leading to more honest reflections on their drinking behaviors. Engaging patients outside the clinical environment can transform the way they perceive their alcohol consumption, fostering a sense of ownership over their health decisions.
Additionally, Dr. Fink’s efforts gain depth and credibility through her participation in specialized programs, such as the recent MIT Bootcamps focused on Substance Use Disorders Ventures, sponsored by the National Institute on Drug Abuse. This boot camp was meticulously constructed to draw innovative solutions for pressing substance use issues. It served as a melting pot of expertise, where Dr. Fink collaborated with a diverse group of professionals skilled in data analytics, machine learning, and public health. Such multidisciplinary collaboration is essential for developing robust solutions that can navigate the complexities of substance use disorders.
The endeavor of Dr. Fink and her colleagues aligns closely with the urgent need to unearth undiagnosed substance use disorders within health systems. Their project aims to refine existing methodologies for recognizing at-risk individuals in varied healthcare settings, extending beyond primary care clinics. This broader scope promises to unveil a greater number of individuals who may benefit from early intervention, thereby improving health outcomes and reinforcing the overall efficacy of healthcare systems.
The culmination of efforts from the MIT Bootcamp saw teams pitching their innovative projects to panels including investors and industry leaders, providing a platform for feedback and insightful guidance on the next steps for particular ventures. This experience not only ignited a sense of renewed motivation for Dr. Fink but also fostered lasting professional relationships that will aid her in future initiatives. She is committed to pursuing novel solutions that extend beyond mere commercial viability, focusing on comprehensive clinical research that benefits the health of populations, particularly Oklahomans.
This initiative embodies a collaborative spirit that underscores the broader importance of addressing substance use disorders. Collaborative partnerships with esteemed individuals and organizations, including critical collaborators like Gilberto Zamora, Ph.D., and Randall Starling, Ph.D., contribute significantly to the endeavor. Their combined expertise provides a solid foundation for achieving impactful results that can reverberate throughout the healthcare landscape. Financial backing from notables like the National Institutes of Health further amplifies the initiative’s potential for global health impact.
As educational institutions such as the University of Oklahoma continue to propel research and clinical practice to the forefront of societal needs, collaborative projects like Fink’s PALMS not only address immediate health issues but also set the stage for future innovations. The implications of this work extend far beyond the individual patient encounter, reshaping how healthcare professionals approach the intricacies of substance use disorders, ultimately leading to profound changes in public health strategies.
Through her preparatory work and innovative tools, Dr. Fink is paving the way for a paradigm shift in how alcohol use is perceived and managed in primary care settings. The development of systems like PALMS signifies a commitment to thorough, responsive healthcare—prompting open conversations about alcohol use and creating pathways toward intervention where they once did not exist. With the right support and collaboration, the strides made in managing substance use disorders can cultivate a healthier, more informed society.
Given the growing recognition of substance use disorders as a critical issue in public health, Dr. Fink’s work stands as a testament to the power of research, innovation, and compassion in transforming healthcare practices. By prioritizing patient engagement, providing tools for assessment, and fostering open dialogues, Dr. Fink is not only addressing a pressing health concern but also instilling hope for a future where individuals feel empowered to reclaim their health and well-being.
As this journey unfolds, it remains essential that healthcare providers continue to seek and implement strategies to engage patients meaningfully. The key to overcoming barriers lies not only in the hands of those providing care but also in the commitment of individuals seeking to understand and address their drinking behaviors. Dr. Fink’s PALMS represents a pivotal step in that direction, and the collective effort to address substance use disorders can move society toward a brighter, healthier future where all individuals have access to the support they require.
Subject of Research: People
Article Title: Innovative Solutions for Addressing Alcohol Use Disorders: Dr. Brandi Fink’s Pioneering Work
News Publication Date: October 2023
Web References: University of Oklahoma
References: None provided
Image Credits: Credit: University of Oklahoma
Keywords: Substance use disorder, alcohol use, PALMS, primary care, public health, Dr. Brandi Fink, University of Oklahoma, clinical trials, intervention strategies.
Tags: alcohol consumption feedbackalcohol use disordersDr. Brandi Fink researchhealthcare provider toolsinnovative health solutionspatient engagement in healthPersonal Alcohol Management Systemprimary care interventionsproactive health assessmentspublic health crisis managementsubstance use disorder statisticstechnology in healthcare
What's Your Reaction?






